NM_178452.6:c.353-18G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_178452.6(DNAAF1):c.353-18G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000131 in 1,612,476 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00012 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00013 ( 4 hom. )
Consequence
DNAAF1
NM_178452.6 intron
NM_178452.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.169
Publications
0 publications found
Genes affected
DNAAF1 (HGNC:30539): (dynein axonemal assembly factor 1) The protein encoded by this gene is cilium-specific and is required for the stability of the ciliary architecture. It is involved in the regulation of microtubule-based cilia and actin-based brush border microvilli. Mutations in this gene are associated with primary ciliary dyskinesia-13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNAAF1 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 13Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 16-84154559-G-A is Benign according to our data. Variant chr16-84154559-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 445734.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000118 (18/152236) while in subpopulation SAS AF = 0.00145 (7/4822). AF 95% confidence interval is 0.00068. There are 0 homozygotes in GnomAd4. There are 10 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 4 AR,AD gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNAAF1 | NM_178452.6 | c.353-18G>A | intron_variant | Intron 3 of 11 | ENST00000378553.10 | NP_848547.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DNAAF1 | ENST00000378553.10 | c.353-18G>A | intron_variant | Intron 3 of 11 | 1 | NM_178452.6 | ENSP00000367815.5 | |||
| DNAAF1 | ENST00000567918.5 | n.353-18G>A | intron_variant | Intron 3 of 6 | 1 | ENSP00000455154.1 | ||||
| DNAAF1 | ENST00000563093.5 | n.353-18G>A | intron_variant | Intron 3 of 10 | 2 | ENSP00000457373.1 | ||||
| DNAAF1 | ENST00000570298.5 | n.507-18G>A | intron_variant | Intron 3 of 10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152118Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
18
AN:
152118
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000243 AC: 61AN: 251034 AF XY: 0.000331 show subpopulations
GnomAD2 exomes
AF:
AC:
61
AN:
251034
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000133 AC: 194AN: 1460240Hom.: 4 Cov.: 31 AF XY: 0.000180 AC XY: 131AN XY: 726510 show subpopulations
GnomAD4 exome
AF:
AC:
194
AN:
1460240
Hom.:
Cov.:
31
AF XY:
AC XY:
131
AN XY:
726510
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33444
American (AMR)
AF:
AC:
4
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26128
East Asian (EAS)
AF:
AC:
3
AN:
39696
South Asian (SAS)
AF:
AC:
141
AN:
86194
European-Finnish (FIN)
AF:
AC:
4
AN:
53380
Middle Eastern (MID)
AF:
AC:
0
AN:
5324
European-Non Finnish (NFE)
AF:
AC:
31
AN:
1111064
Other (OTH)
AF:
AC:
11
AN:
60294
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
13
26
39
52
65
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000118 AC: 18AN: 152236Hom.: 0 Cov.: 31 AF XY: 0.000134 AC XY: 10AN XY: 74432 show subpopulations
GnomAD4 genome
AF:
AC:
18
AN:
152236
Hom.:
Cov.:
31
AF XY:
AC XY:
10
AN XY:
74432
show subpopulations
African (AFR)
AF:
AC:
2
AN:
41536
American (AMR)
AF:
AC:
0
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
4
AN:
5182
South Asian (SAS)
AF:
AC:
7
AN:
4822
European-Finnish (FIN)
AF:
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5
AN:
68022
Other (OTH)
AF:
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1
Aug 01, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Primary ciliary dyskinesia Benign:1
Jul 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.